This phenomenon is not likely to be limited to colon cancer as several other groups have demonstrated a requirement for AMPK or its downstream effects in both prostate and breast cancer and have shown that inhibition of AMPK is detrimental to cancer cells32–36. This evidence concerns the gene PRKAA1 and breast cancer.